Monopar Therapeutics reports insider trading.
- Christopher M Starr sold 4,631 shares at $78.09
- Starr sold 2,970 shares at $78.82
- Starr sold 799 shares at $79.67
Christopher M Starr
MNPR
Monopar Therapeutics SEC filings
Every EDGAR filing for Monopar Therapeutics (MNPR), newest first, with AI summaries and stories.
- Ticker
- MNPR
- CIK
- 1645469
- Latest filing
- Oct 5
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 7 open-market sales ($3.2M), 9 grants or exercises.
Filings
4Monopar TherapeuticsMNPRLIVE 4Monopar TherapeuticsMNPRLIVE 3 insider filings
Quan Anh Vu, insider filing for MNPR
Show all 3
- 4Insider filing for MNPR
- 4Insider filing for MNPR
- 4Insider filing for MNPR
Quan Anh Vu
144Monopar TherapeuticsMNPRLIVE Christopher M Starr, planned sale of MNPR shares
Christopher M Starr
4Monopar TherapeuticsMNPRLIVE Chandler Robinson, insider filing for MNPR
Chandler Robinson, reporting
144Monopar TherapeuticsMNPRLIVE Chandler Robinson, planned sale of MNPR shares
Chandler Robinson, reporting
4/AMonopar TherapeuticsMNPRLIVE Kim R Tsuchimoto, insider filing for MNPR (amended)
Kim R Tsuchimoto, reporting
4/AMonopar TherapeuticsMNPRLIVE Raymond Anderson, insider filing for MNPR (amended)
Raymond Anderson, reporting
4Monopar TherapeuticsMNPRLIVE Patrice Rioux, insider filing for MNPR
Patrice Rioux, reporting
4Monopar TherapeuticsMNPRLIVE 2 insider filings
Kim R Tsuchimoto, insider filing for MNPR
Show all 2
- 4Insider filing for MNPR
- 4Insider filing for MNPR
Kim R Tsuchimoto, reporting
144Monopar TherapeuticsMNPRLIVE 2 Form 144 notices
Patrice Rioux, planned sale of MNPR shares
Show all 2
- 144Planned insider sale of MNPR shares
- 144Planned insider sale of MNPR shares
Patrice Rioux, reporting
144Monopar TherapeuticsMNPRLIVE Raymond Anderson, planned sale of MNPR shares
Raymond Anderson, reporting
SCHEDULE 13G/AMonopar TherapeuticsMNPRLIVE Ownership stake disclosure by Saturn V Capital Management LP (amended)
Saturn V Capital Management LP, filed by
SCHEDULE 13G/AMonopar TherapeuticsMNPRLIVE Ownership stake disclosure by Adage Capital Management, L.P. (amended)
Adage Capital Management, L.P., filed by
8-KMonopar TherapeuticsMNPRLIVE 10-QMonopar TherapeuticsMNPRLIVE S-8 POSMonopar TherapeuticsMNPRLIVE S-8 POSMonopar TherapeuticsMNPRLIVE S-8 POSMonopar TherapeuticsMNPRLIVE S-8Monopar TherapeuticsMNPRLIVE S-8 POSMonopar TherapeuticsMNPRLIVE 8-KMonopar TherapeuticsMNPRLIVE 144/AMonopar TherapeuticsMNPRLIVE Arthur J Klausner, planned sale of MNPR shares (amended)
Arthur J Klausner, reporting
144Monopar TherapeuticsMNPRLIVE Arthur J Klausner, planned sale of MNPR shares
Arthur J Klausner, reporting
4Monopar TherapeuticsMNPRLIVE 3 insider filings
Quan Anh Vu, insider filing for MNPR
Show all 3
- 4Insider filing for MNPR
- 4Insider filing for MNPR
- 4Insider filing for MNPR
Quan Anh Vu, reporting
4Monopar TherapeuticsMNPRLIVE 2 insider filings
Nicole Sweeny, insider filing for MNPR
Show all 2
- 4Insider filing for MNPR
- 3New insider at MNPR
Nicole Sweeny, reporting
8-KMonopar TherapeuticsMNPRLIVE 8-KMonopar TherapeuticsMNPRLIVE 8-KMonopar TherapeuticsMNPRLIVE 8-KMonopar TherapeuticsMNPRLIVE 8-KMonopar TherapeuticsMNPRLIVE SCHEDULE 13GMonopar TherapeuticsMNPRLIVE Ownership stake disclosure by Saturn V Capital Management LP
Saturn V Capital Management LP, filed by
10-QMonopar TherapeuticsMNPRLIVE 8-KMonopar TherapeuticsMNPRLIVE SCHEDULE 13G/AMonopar TherapeuticsMNPRLIVE Ownership stake disclosure by Adage Capital Management, L.P. (amended)
Adage Capital Management, L.P., filed by
ARSMonopar TherapeuticsMNPRLIVE DEFA14AMonopar TherapeuticsMNPRLIVE DEF 14AMonopar TherapeuticsMNPRLIVE 8-KMonopar TherapeuticsMNPRLIVE 4Monopar TherapeuticsMNPRLIVE 2 insider filings
Chandler Robinson, insider filing for MNPR
Show all 2
- 4Insider filing for MNPR
- 4Insider filing for MNPR
Chandler Robinson, reporting
10-K/AMonopar TherapeuticsMNPRLIVE 8-KMonopar TherapeuticsMNPRLIVE 10-KMonopar TherapeuticsMNPRLIVE